Indication
Cutaneous leishmaniasis
Cutaneous leishmaniasis is a vector-borne infectious disease of the integumentary system caused by obligate intracellular protozoan parasites of the genus *Leishmania*, transmitted to humans through the bites of infected female phlebotomine sand flies. Read more about Cutaneous leishmaniasis
2 drugs 2 manufacturers
Drugs that treat it
Common Cutaneous leishmaniasis therapies.
IMPAVIDO (miltefosine)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCutaneous leishmaniasis is a vector-borne infectious disease of the integumentary system caused by obligate intracellular protozoan parasites of the genus *Leishmania*, transmitted to humans through the bites of infected female phlebotomine sand flies.
Pathophysiologically, the parasites infect dermal macrophages and reticuloendothelial cells, initiating a local granulomatous inflammatory cascade that develops over weeks to months.
Defining clinical features begin as localized erythematous papules or nodules that typically advance into painless, crusted ulcerative plaques with raised borders and central depressions, which may heal slowly with permanent, disfiguring scars.
The condition primarily impacts populations living in or traveling to endemic tropical, subtropical, and Mediterranean regions.
- dndi.org
Cutaneous leishmaniasis is a vector-borne infectious disease of the integumentary system caused by obligate intracellular protozoan parasites of the genus *Leishmania*, transmitted to humans through the bites of infected female phlebotomine sand flies
- nih.gov
Cutaneous leishmaniasis is a vector-borne infectious disease of the integumentary system caused by obligate intracellular protozoan parasites of the genus *Leishmania*, transmitted to humans through the bites of infected female phlebotomine sand flies
- cdc.gov
Pathophysiologically, the parasites infect dermal macrophages and reticuloendothelial cells, initiating a local granulomatous inflammatory cascade that develops over weeks to months
- cdc.gov
Pathophysiologically, the parasites infect dermal macrophages and reticuloendothelial cells, initiating a local granulomatous inflammatory cascade that develops over weeks to months Defining clinical features begin as localized erythematous papules or nodules that typically advance into painless, crusted ulcerative plaques with raised borders and central depressions, which may heal slowly with permanent, disfiguring scars
- nih.gov
Defining clinical features begin as localized erythematous papules or nodules that typically advance into painless, crusted ulcerative plaques with raised borders and central depressions, which may heal slowly with permanent, disfiguring scars The condition primarily impacts populations living in or traveling to endemic tropical, subtropical, and Mediterranean regions
- nih.gov
The condition primarily impacts populations living in or traveling to endemic tropical, subtropical, and Mediterranean regions
Personalize your experience
Follow Cutaneous leishmaniasis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.